All of these arguments support Gal-1 as a negative prognosis factor in different types of cancers and reveal the importance of evaluating conditioning strategies as an exciting opportunity to shape tumor fate by targeting this lectin in the tumor microenvironment. This evidence concerns the gene LGALS1 and neoplasm.